Daniel Williams

Daniel Williams is a seasoned professional in clinical quality assurance and compliance, currently serving as the Director of Clinical Quality at Compass Pathways since August 2024. Prior experience includes serving as VP of Quality at Barinthus Biotherapeutics and Director of Clinical Quality Assurance at Eisai EMEA, where responsibilities encompassed the global CQA strategy, audit management, and oversight of quality systems. Williams held various leadership roles at Janssen, including Associate Director positions in Business Development and Global R&D QA, and has a strong foundation in quality assurance from previous roles at Covance, Bayer HealthCare PLC, Wyeth, and Leicester Clinical Research Centre. Academic credentials include a Bachelor of Science in Applied Science, specializing in Biology and Geology, from the University of Glamorgan.